Trials / Completed
CompletedNCT00473681
Intervention Study to Control High Blood Pressure for Korean American
High Blood Pressure Care for Korean Americans
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 445 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the proposed clinical trials is to compare the differential reduction in blood pressure in underserved hypertensive adult Korean American. The study is designed to test the effectiveness of a comprehensive self-help intervention program.
Detailed description
CVD is the leading cause of mortality among KA. Recent statistics underscoring the high prevalence and impact of uncontrolled HBP upon this population warrant the development and implementation of effective intervention. KA experiences a great deal of social isolation, which makes it more difficult for them to make behavioral changes for health improvement. individual, family, and community behaviors are part of the HBP problem and also constitute major part of the solution. The proposed research is designed to investigate these issues in a KA population and to lay the groundwork for community-based self-help health education interventions to enhance appropriate care and BP control. Comparison(s):This community-based self-help intervention approach offers a more culturally appropriate approach to closing the health status gap for KA. Incorporating a partnership with community leaders and health and human service care providers, this approach will utilize state-of-the-art health education strategies and a well-trained bilingual nurse from the community.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Self-Help Intervention Program-High Blood Pressure |
Timeline
- Start date
- 2003-09-01
- Primary completion
- 2006-08-01
- Completion
- 2007-08-01
- First posted
- 2007-05-15
- Last updated
- 2008-05-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00473681. Inclusion in this directory is not an endorsement.